Gov't authorizes COVID-19 vaccine from Pfizer and BioNTech

Non-clinical data showed better response compared to the Omicron XBB.1.5-adapted vaccine.

The Health Sciences Authority has authorised Pfizer and BioNTech SE’s updated COVID-19 vaccine tailored to the Omicron JN.1 variant, making Singapore the first Southeast Asian country to receive full approval.

The approval was based on manufacturing and non-clinical immunogenicity evaluation, leveraging on previous clinical data to support the safety and effectiveness of Pfizer-BioNTech’s COVID-19 vaccines.

The non-clinical data showed that the Omicron JN.1-adapted vaccine responds better against the circulating variant compared to the Omicron XBB.1.5-adapted vaccine.

The vaccine is expected to enhance protection against current strains, particularly for high-risk populations such as the elderly and individuals with pre-existing conditions.

Follow the link for more news on

Pfizer

COVID-19

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia

Top News

Specialty chemicals manufacturing facility on Jurong Island for sale

The fully equipped facility is clean and ready to be recommissioned.

Commercial Property

10 hours ago

September surge masks looming export slowdown to 6% in 2027

Maybank raised its 2026 forecast to 27% from 18% in the same report.Non-oil domestic exports (NODX) growth could slow to 6% in 2027 as supply chain pressures and higher financing costs weigh on shipment momentum, Maybank Research Pte Ltd said.

Economy

14 hours ago

Nearly half of workers report six or more unpaid hours a week, report says